US2023330105A1PendingUtilityA1

Methods and compositions for topical delivery of prostaglandins to subcutaneous fat

Assignee: TOPOKINE THERAPEUTICS INCPriority: May 15, 2013Filed: Jan 31, 2023Published: Oct 19, 2023
Est. expiryMay 15, 2033(~6.8 yrs left)· nominal 20-yr term from priority
A61K 31/5575A61K 8/34A61K 8/345A61K 8/361A61K 8/37A61K 8/69A61K 9/0014A61K 47/10A61K 47/12A61Q 19/06
80
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are compositions comprising a prostaglandin FP receptor agonist (PFPRA) compound and a fatty acid, e.g., oleic acid, that, when topically applied to the skin, locally delivers a therapeutically effective amount of the PFPRA compound or active metabolite thereof to subcutaneous fat under the skin. The therapeutic effect is, for example, reduction of the subcutaneous fat under the skin. Further provided are methods of reducing body fat in a subject comprising topically administering the composition to the subject. The present invention also provides kits comprising the composition and instructions for use.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition comprising latanoprost and oleic acid. 
     
     
         2 - 18 . (canceled)

Join the waitlist — get patent alerts

Track US2023330105A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.